市場調査レポート

商品コード

1315705

動物用分子診断市場：製品、技術、動物タイプ、適応疾患、エンドユーザー別-2023-2030年の世界予測

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 746,257円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 903,397円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,060,537円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,374,817円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

動物用分子診断の世界市場は、2023年に5億7,974万米ドル、CAGR 9.15%と大きく成長し、2030年には10億7,185万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の動物用分子診断市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.動物用分子診断の世界市場規模および予測は？

2.予測期間中、世界の動物用分子診断市場を形成するCOVID-19の阻害要因と影響は？

3.動物用分子診断の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.動物用分子診断の世界市場における競争戦略は？

5.動物用分子診断の世界市場における技術動向と規制の枠組みは？

6.動物用分子診断の世界市場における主要ベンダーの市場シェアは？

7.動物用分子診断の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 愛玩動物や家畜の所有数の増加
  - 経済圏における獣医療施設の改善
  - 動物の慢性疾患の発生率の増加
- 抑制要因
  - 高度な分子診断機器とアッセイに伴う高コスト
- 機会
  - 動物用分子診断テクノロジーの進歩
  - ペット保険の利用可能範囲が拡大
- 課題
  - 熟練した専門家の不足
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章動物用分子診断市場：製品別

機器とソフトウェア
キットと試薬
サービス

第7章動物用分子診断市場：技術別

DNA配列決定
マイクロアレイ
ポリメラーゼ連鎖反応

第8章動物用分子診断市場動物の種類別

コンパニオンアニマル
- 犬科
- 馬
- ネコ科の動物
家畜
- ウシ
- ヒツジまたはヤギ
- ブタ
- 家禽

第9章動物用分子診断市場：疾患適応症別

下痢病原体の検出
呼吸器病原体の検出
ベクター媒介疾患

第10章動物用分子診断市場：エンドユーザー別

病院
リファレンスラボ
獣医クリニック

第11章南北アメリカの動物用分子診断市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域の動物用分子診断市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカの動物用分子診断市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2022 VS 2030
FIGURE 3. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2030 (%)
FIGURE 7. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2030 (%)
FIGURE 8. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 9. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
FIGURE 11. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 9. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 13. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 14. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 19. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 58. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 59. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 95. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 96. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 102. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 103. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 116. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 117. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 158. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 159. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 180. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 181. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 187. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 188. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 222. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 223. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 243. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 250. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 251. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 257. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 258. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 285. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 286. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTI

Product Code: MRR-034B50030398

The Global Veterinary Molecular Diagnostic Market is forecasted to grow significantly, with a projected USD 579.74 million in 2023 at a CAGR of 9.15% and expected to reach a staggering USD 1,071.85 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Veterinary Molecular Diagnostic Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Veterinary Molecular Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments & Software, Kits & Reagent, and Services. The Services is projected to witness significant market share during forecast period.

Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction. The Microarrays is projected to witness significant market share during forecast period.

Based on Animal Type, market is studied across Companion Animal and Livestock Animal. The Companion Animal is further studied across Canine, Equine, and Feline. The Livestock Animal is further studied across Bovine, Ovine or Caprine, Porcine, and Poultry. The Companion Animal is projected to witness significant market share during forecast period.

Based on Disease Indication, market is studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases. The Diarrhea Pathogens Detection is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals, Reference Laboratories, and Veternary Clinics. The Veternary Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Veterinary Molecular Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Veterinary Molecular Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Molecular Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Molecular Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Veterinary Molecular Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Veterinary Molecular Diagnostic Market?

6. What is the market share of the leading vendors in the Global Veterinary Molecular Diagnostic Market?

7. What modes and strategic moves are considered suitable for entering the Global Veterinary Molecular Diagnostic Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Veterinary Molecular Diagnostic Market, by Product, 2022 vs 2030
4.3. Veterinary Molecular Diagnostic Market, by Technology, 2022 vs 2030
4.4. Veterinary Molecular Diagnostic Market, by Animal Type, 2022 vs 2030
4.5. Veterinary Molecular Diagnostic Market, by Disease Indication, 2022 vs 2030
4.6. Veterinary Molecular Diagnostic Market, by End User, 2022 vs 2030
4.7. Veterinary Molecular Diagnostic Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of companion animal and livestock ownership
  - 5.1.1.2. Improving veterinary care facilities in economies
  - 5.1.1.3. Rising incidence of chronic diseases in animals
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
- 5.1.3. Opportunities
  - 5.1.3.1. Advances in veterinary molecular diagnostic technology
  - 5.1.3.2. Growing availability of pet insurance
- 5.1.4. Challenges
  - 5.1.4.1. Lack of skilled professionals
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Veterinary Molecular Diagnostic Market, by Product

6.1. Introduction
6.2. Instruments & Software
6.3. Kits & Reagent
6.4. Services

7. Veterinary Molecular Diagnostic Market, by Technology

7.1. Introduction
7.2. DNA Sequencing
7.3. Microarrays
7.4. Polymerase Chain Reaction

8. Veterinary Molecular Diagnostic Market, by Animal Type

8.1. Introduction
8.2. Companion Animal
- 8.2.1. Canine
- 8.2.2. Equine
- 8.2.3. Feline
8.3. Livestock Animal
- 8.3.1. Bovine
- 8.3.2. Ovine or Caprine
- 8.3.3. Porcine
- 8.3.4. Poultry

9. Veterinary Molecular Diagnostic Market, by Disease Indication

9.1. Introduction
9.2. Diarrhea Pathogens Detection
9.3. Respiratory Pathogens Detection
9.4. Vector Borne Diseases

10. Veterinary Molecular Diagnostic Market, by End User

10.1. Introduction
10.2. Hospitals
10.3. Reference Laboratories
10.4. Veternary Clinics

11. Americas Veterinary Molecular Diagnostic Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Veterinary Molecular Diagnostic Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

動物用分子診断市場：製品、技術、動物タイプ、適応疾患、エンドユーザー別-2023-2030年の世界予測

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 動物用分子診断市場：製品別

第7章 動物用分子診断市場：技術別

第8章 動物用分子診断市場動物の種類別

第9章 動物用分子診断市場：疾患適応症別

第10章 動物用分子診断市場：エンドユーザー別

第11章 南北アメリカの動物用分子診断市場

第12章 アジア太平洋地域の動物用分子診断市場

第13章 欧州・中東・アフリカの動物用分子診断市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録